These are transformational therapies for many patients with dyslipidemia, including those with HeFH and those with a high ASCVD risk whose LDL-C levels cannot be adequately controlled with existing therapies. The PCSK9 target remains popular, as evidenced by ongoing development of inhibition by an ...
DDxHub - Differential diagnosis Hub is the System distinguishing of a particular disease or health condition from others that present similar symptoms and lab test results.
1374 subjects aged > 40 years and with at least one risk factor (hypertension, dyslipidemia, obesity, vascular disease, diabetes mellitus) or cardiovascular
Fish oil to reduce atherogenic apob-remnant dyslipidemia and subclinical ACVD in high-risk women with and without PCOS Donna Vine University of Alberta Risk Evaluation and Stratification of Low Risk for Cardiovascular Disease in Women (RESOLVE) Elsie Nguyen University of Toronto Sex differences in ...
Increased instances of complications such as hypertension, non-insulin-dependent diabetes mellitus, arteriosclerosis, dyslipidemia, certain forms of cancer, sleep apnea, and osteoarthritis have been related to increased instances of obesity in the general population In one aspect, the invention encompasses ...
He was a 55-year-old man referred to a hospital for a nephrotic syn- drome study, on the basis of a casual finding of high protein- uria in a periodic analytical control. There was no familial history of renal disease, but he and his father and brothers are diagnosed with dyslipidemia ...
(OHIP) as of the study start date used as proxy to determine new immigrant status; dDiabetes related complication including: coronary artery disease, hypertension, chronic obstructive pulmonary disease, polycystic ovarian syndrome, dyslipidemia, stroke/transient ischemic attack, erectile dysfunction, ...
Liver enzymes have been suggested as useful markers for diagnosing NAFLD [16,17,18]. In addition, due to the detection of dyslipidemia in Indian patients with NAFLD, serum lipids were suggested as possible disease markers [19]. Various other biomarkers were also suggested, with conflicting ...
Collectively, these findings suggest that inhibition of ANGPTL3 provides new opportunities for lowering lipids and managing residual cardiovascular risk, especially in patients at high risk with refractory dyslipidemia. Future, studies on the effects of ANGPTL3 inhibition on atherosclerotic CVD outcomes are...
The most common conditions associated with obesity are diabetes, hepatic steatosis, cardiovascular diseases, stroke, dyslipidemia, hypertension, gallbladder problems, osteoarthritis, sleep apnea, and other breathing problems; in addition, obese people also show an increased risk of getting some types of ...